 Jennie Buchanan
Concepts (192)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Levamisole | 5 | 2026 | 21 | 1.590 |
Why?
| | Cocaine | 7 | 2026 | 160 | 1.580 |
Why?
| | Drug Contamination | 5 | 2026 | 52 | 1.330 |
Why?
| | Sex Offenses | 7 | 2025 | 196 | 0.970 |
Why?
| | Emergency Medicine | 4 | 2023 | 261 | 0.950 |
Why?
| | Emergency Service, Hospital | 13 | 2025 | 2310 | 0.910 |
Why?
| | Agranulocytosis | 3 | 2012 | 30 | 0.770 |
Why?
| | Toxicology | 4 | 2026 | 49 | 0.720 |
Why?
| | Methylene Chloride | 1 | 2021 | 5 | 0.670 |
Why?
| | Dopamine Uptake Inhibitors | 2 | 2011 | 58 | 0.660 |
Why?
| | Argyria | 1 | 2020 | 4 | 0.650 |
Why?
| | Silver | 1 | 2020 | 38 | 0.630 |
Why?
| | Skin Diseases | 1 | 2021 | 149 | 0.580 |
Why?
| | Resuscitation | 1 | 2020 | 302 | 0.530 |
Why?
| | Survivors | 4 | 2025 | 520 | 0.530 |
Why?
| | Drug Overdose | 5 | 2026 | 370 | 0.520 |
Why?
| | Occupational Exposure | 1 | 2021 | 354 | 0.500 |
Why?
| | Internship and Residency | 4 | 2025 | 1257 | 0.490 |
Why?
| | Lithium Compounds | 1 | 2015 | 11 | 0.470 |
Why?
| | Stress Disorders, Post-Traumatic | 5 | 2025 | 893 | 0.460 |
Why?
| | Tea Tree Oil | 1 | 2015 | 2 | 0.450 |
Why?
| | Exanthema | 2 | 2012 | 84 | 0.440 |
Why?
| | Antidotes | 3 | 2014 | 145 | 0.440 |
Why?
| | Nausea | 2 | 2012 | 111 | 0.430 |
Why?
| | Pediatrics | 2 | 2020 | 1114 | 0.430 |
Why?
| | Pulmonary Surfactants | 1 | 2015 | 102 | 0.420 |
Why?
| | Clinical Competence | 3 | 2025 | 1244 | 0.420 |
Why?
| | Flecainide | 1 | 2012 | 8 | 0.370 |
Why?
| | Sulfhydryl Reagents | 1 | 2012 | 12 | 0.370 |
Why?
| | Tachycardia | 1 | 2012 | 57 | 0.360 |
Why?
| | Antinematodal Agents | 1 | 2012 | 7 | 0.360 |
Why?
| | Arsenicals | 1 | 2012 | 28 | 0.360 |
Why?
| | Acute Generalized Exanthematous Pustulosis | 1 | 2011 | 4 | 0.360 |
Why?
| | Pharmacy | 1 | 2012 | 33 | 0.360 |
Why?
| | Cephalexin | 1 | 2011 | 14 | 0.350 |
Why?
| | Chickenpox | 1 | 2012 | 81 | 0.350 |
Why?
| | Crime | 2 | 2011 | 60 | 0.350 |
Why?
| | Drug Compounding | 1 | 2012 | 107 | 0.350 |
Why?
| | Curriculum | 3 | 2026 | 1059 | 0.340 |
Why?
| | Respiratory Insufficiency | 1 | 2015 | 326 | 0.340 |
Why?
| | Sulfides | 1 | 2012 | 91 | 0.340 |
Why?
| | Renal Dialysis | 1 | 2015 | 462 | 0.340 |
Why?
| | Skin Diseases, Vascular | 1 | 2011 | 8 | 0.340 |
Why?
| | Anthelmintics | 1 | 2011 | 12 | 0.340 |
Why?
| | Facial Injuries | 1 | 2011 | 24 | 0.340 |
Why?
| | Nasal Septum | 1 | 2011 | 30 | 0.340 |
Why?
| | Hematoma | 1 | 2011 | 59 | 0.330 |
Why?
| | Suicide, Attempted | 2 | 2012 | 422 | 0.330 |
Why?
| | Depression | 2 | 2024 | 1558 | 0.330 |
Why?
| | Foreign Bodies | 2 | 2011 | 107 | 0.330 |
Why?
| | Vasculitis | 1 | 2011 | 69 | 0.320 |
Why?
| | Ethylene Glycol | 1 | 2010 | 15 | 0.320 |
Why?
| | Education, Medical | 2 | 2025 | 274 | 0.310 |
Why?
| | Cocaine-Related Disorders | 1 | 2011 | 132 | 0.300 |
Why?
| | Adjuvants, Immunologic | 1 | 2011 | 245 | 0.300 |
Why?
| | Fellowships and Scholarships | 2 | 2026 | 357 | 0.300 |
Why?
| | Skin | 4 | 2020 | 755 | 0.300 |
Why?
| | Humans | 43 | 2026 | 144759 | 0.290 |
Why?
| | Faculty, Medical | 2 | 2023 | 302 | 0.280 |
Why?
| | Pneumonia, Viral | 1 | 2012 | 384 | 0.260 |
Why?
| | Adult | 21 | 2026 | 40449 | 0.240 |
Why?
| | Crime Victims | 2 | 2025 | 129 | 0.240 |
Why?
| | Pyrazoles | 1 | 2010 | 509 | 0.240 |
Why?
| | Male | 21 | 2026 | 72315 | 0.230 |
Why?
| | Police | 1 | 2025 | 45 | 0.220 |
Why?
| | Referral and Consultation | 2 | 2025 | 851 | 0.220 |
Why?
| | Education, Distance | 1 | 2025 | 61 | 0.210 |
Why?
| | Young Adult | 12 | 2026 | 14105 | 0.210 |
Why?
| | Middle Aged | 17 | 2026 | 35875 | 0.210 |
Why?
| | Benzodiazepines | 1 | 2025 | 167 | 0.210 |
Why?
| | Hyperhidrosis | 1 | 2023 | 7 | 0.200 |
Why?
| | Mydriasis | 1 | 2023 | 10 | 0.200 |
Why?
| | Urinary Retention | 1 | 2023 | 25 | 0.200 |
Why?
| | Fentanyl | 1 | 2024 | 127 | 0.200 |
Why?
| | Adenosine Monophosphate | 1 | 2024 | 86 | 0.190 |
Why?
| | Simulation Training | 1 | 2025 | 134 | 0.190 |
Why?
| | Alanine | 1 | 2024 | 171 | 0.190 |
Why?
| | Analgesics, Opioid | 3 | 2026 | 1143 | 0.180 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2023 | 257 | 0.170 |
Why?
| | Prospective Studies | 8 | 2025 | 7990 | 0.170 |
Why?
| | Anti-Bacterial Agents | 1 | 2011 | 1907 | 0.170 |
Why?
| | Compartment Syndromes | 1 | 2021 | 36 | 0.160 |
Why?
| | Problem Solving | 1 | 2020 | 156 | 0.150 |
Why?
| | Female | 22 | 2026 | 78271 | 0.150 |
Why?
| | Colubridae | 1 | 2018 | 9 | 0.140 |
Why?
| | Snake Venoms | 1 | 2018 | 20 | 0.140 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2023 | 428 | 0.140 |
Why?
| | Pediatricians | 1 | 2020 | 121 | 0.140 |
Why?
| | Snake Bites | 1 | 2018 | 24 | 0.140 |
Why?
| | Educational Status | 1 | 2020 | 467 | 0.140 |
Why?
| | Healthcare Disparities | 1 | 2025 | 727 | 0.140 |
Why?
| | Eating | 1 | 2020 | 389 | 0.130 |
Why?
| | Poisoning | 2 | 2015 | 119 | 0.130 |
Why?
| | Opioid-Related Disorders | 1 | 2026 | 600 | 0.130 |
Why?
| | Emergency Medical Services | 2 | 2024 | 696 | 0.130 |
Why?
| | Anxiety | 2 | 2024 | 1109 | 0.130 |
Why?
| | Thrombocytopenia | 1 | 2018 | 205 | 0.120 |
Why?
| | Lithium Carbonate | 1 | 2015 | 6 | 0.120 |
Why?
| | Deglutition | 1 | 2015 | 72 | 0.110 |
Why?
| | United States | 6 | 2026 | 15966 | 0.110 |
Why?
| | Critical Illness | 1 | 2020 | 891 | 0.100 |
Why?
| | Tertiary Care Centers | 1 | 2015 | 189 | 0.100 |
Why?
| | Naloxone | 2 | 2025 | 132 | 0.100 |
Why?
| | Acetylcysteine | 1 | 2014 | 139 | 0.100 |
Why?
| | Administration, Oral | 2 | 2014 | 847 | 0.100 |
Why?
| | Alanine Transaminase | 2 | 2024 | 151 | 0.100 |
Why?
| | Narcotic Antagonists | 2 | 2025 | 205 | 0.090 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2014 | 139 | 0.090 |
Why?
| | Therapeutic Irrigation | 1 | 2012 | 69 | 0.090 |
Why?
| | Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2011 | 8 | 0.090 |
Why?
| | Veterinary Drugs | 1 | 2011 | 2 | 0.090 |
Why?
| | Acetaminophen | 1 | 2014 | 264 | 0.090 |
Why?
| | False Negative Reactions | 1 | 2011 | 60 | 0.090 |
Why?
| | Infant | 3 | 2015 | 10034 | 0.080 |
Why?
| | Ear, External | 1 | 2011 | 21 | 0.080 |
Why?
| | Leukoencephalopathies | 1 | 2011 | 24 | 0.080 |
Why?
| | Hospitals, Pediatric | 1 | 2015 | 556 | 0.080 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2011 | 131 | 0.080 |
Why?
| | Prevalence | 2 | 2024 | 2834 | 0.080 |
Why?
| | Fluid Therapy | 1 | 2012 | 147 | 0.080 |
Why?
| | Fever | 1 | 2012 | 311 | 0.080 |
Why?
| | Immunoassay | 1 | 2011 | 109 | 0.080 |
Why?
| | Crack Cocaine | 1 | 2010 | 8 | 0.080 |
Why?
| | Hospitals, Urban | 1 | 2011 | 144 | 0.080 |
Why?
| | Leukopenia | 1 | 2010 | 33 | 0.080 |
Why?
| | Half-Life | 1 | 2010 | 151 | 0.080 |
Why?
| | Injections, Intravenous | 1 | 2010 | 200 | 0.080 |
Why?
| | Necrosis | 1 | 2011 | 244 | 0.080 |
Why?
| | Radiography | 1 | 2012 | 844 | 0.080 |
Why?
| | Adolescent | 7 | 2025 | 22428 | 0.080 |
Why?
| | Reproducibility of Results | 2 | 2024 | 3409 | 0.080 |
Why?
| | Blood Chemical Analysis | 1 | 2010 | 109 | 0.080 |
Why?
| | Accidents, Traffic | 1 | 2011 | 190 | 0.080 |
Why?
| | Leukocyte Count | 1 | 2010 | 316 | 0.080 |
Why?
| | Neutropenia | 1 | 2010 | 155 | 0.070 |
Why?
| | Intestines | 1 | 2012 | 358 | 0.070 |
Why?
| | HIV Infections | 1 | 2024 | 3154 | 0.070 |
Why?
| | Infant, Newborn | 1 | 2020 | 6429 | 0.070 |
Why?
| | Bone Marrow | 1 | 2010 | 304 | 0.070 |
Why?
| | Pharmacy Service, Hospital | 1 | 2009 | 81 | 0.070 |
Why?
| | Time Factors | 3 | 2020 | 7173 | 0.070 |
Why?
| | Aged, 80 and over | 1 | 2020 | 8265 | 0.070 |
Why?
| | Pain | 2 | 2024 | 779 | 0.070 |
Why?
| | Treatment Outcome | 1 | 2021 | 11679 | 0.060 |
Why?
| | India | 1 | 2025 | 218 | 0.060 |
Why?
| | Missouri | 1 | 2024 | 66 | 0.050 |
Why?
| | Pennsylvania | 1 | 2024 | 138 | 0.050 |
Why?
| | Delphi Technique | 1 | 2026 | 329 | 0.050 |
Why?
| | Glycopyrrolate | 1 | 2023 | 2 | 0.050 |
Why?
| | Cohort Studies | 2 | 2024 | 5960 | 0.050 |
Why?
| | Consensus | 1 | 2026 | 488 | 0.050 |
Why?
| | Piperidines | 1 | 2024 | 217 | 0.050 |
Why?
| | Educational Measurement | 1 | 2025 | 326 | 0.050 |
Why?
| | Colorado | 2 | 2024 | 4564 | 0.040 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2024 | 541 | 0.040 |
Why?
| | Buprenorphine | 1 | 2025 | 190 | 0.040 |
Why?
| | Arousal | 1 | 2022 | 157 | 0.040 |
Why?
| | Residence Characteristics | 1 | 2024 | 377 | 0.040 |
Why?
| | Computer Simulation | 1 | 2025 | 1025 | 0.040 |
Why?
| | Orbit | 1 | 2021 | 64 | 0.040 |
Why?
| | Students, Medical | 1 | 2025 | 375 | 0.040 |
Why?
| | Needs Assessment | 1 | 2023 | 404 | 0.040 |
Why?
| | Pediatric Emergency Medicine | 1 | 2020 | 23 | 0.040 |
Why?
| | Medical Staff, Hospital | 1 | 2020 | 80 | 0.040 |
Why?
| | Blister | 1 | 2018 | 39 | 0.040 |
Why?
| | Surveys and Questionnaires | 2 | 2023 | 6048 | 0.040 |
Why?
| | Risk Factors | 2 | 2024 | 10779 | 0.030 |
Why?
| | Edema | 1 | 2018 | 124 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2024 | 767 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2025 | 2947 | 0.030 |
Why?
| | Focus Groups | 1 | 2020 | 573 | 0.030 |
Why?
| | Guideline Adherence | 1 | 2020 | 589 | 0.030 |
Why?
| | Registries | 1 | 2024 | 2385 | 0.030 |
Why?
| | Retrospective Studies | 3 | 2024 | 17066 | 0.030 |
Why?
| | Pandemics | 1 | 2023 | 1694 | 0.030 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2015 | 98 | 0.030 |
Why?
| | Poison Control Centers | 1 | 2015 | 84 | 0.030 |
Why?
| | Patient Readmission | 1 | 2020 | 758 | 0.030 |
Why?
| | Length of Stay | 1 | 2020 | 1337 | 0.030 |
Why?
| | Patient Acceptance of Health Care | 1 | 2020 | 885 | 0.020 |
Why?
| | Administration, Intravenous | 1 | 2014 | 170 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 5868 | 0.020 |
Why?
| | Pregnancy | 1 | 2023 | 7190 | 0.020 |
Why?
| | Body Weight | 1 | 2014 | 976 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 2027 | 0.020 |
Why?
| | Watchful Waiting | 1 | 2010 | 89 | 0.020 |
Why?
| | Drug Storage | 1 | 2009 | 53 | 0.020 |
Why?
| | Drug Utilization | 1 | 2009 | 166 | 0.020 |
Why?
| | Child | 2 | 2020 | 22633 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2009 | 732 | 0.010 |
Why?
| | Child, Preschool | 1 | 2015 | 11787 | 0.010 |
Why?
| | Animals | 1 | 2018 | 38058 | 0.010 |
Why?
|
|
Buchanan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|